marcus evans europe conferences

20th Annual Strategic Project & Portfolio Management for Pharma

Refocus your strategy with the right prioritisation and project valuation in times of unprecedented disruption

27-29 January 2021
Berlin, Germany


Why You Should Attend

20th Annual Strategic Project & Portfolio Management for Pharma

With increased impact from the pandemic, pharma and biotech companies are under pressure to deliver results and adapt to new business realities with a fresh approach to PPM. Covid-19 and its aftermath have brought into focus the need to prioritize better and deliver results under increased budget constraints. Project selection and portfolio valuation are crucial tools for PPM managers to understand their competitive advantage, core portfolio values and market forecasts, and to align with their strategic corporate objectives.

This marcus evans unique conference will discuss how you can articulate your priorities better in a COVID-19 environment, and how to overcome increased reporting overload and drive a positive impact in your portfolio strategy. We will explore strategic modeling in times of uncertainty, and how to align R&D and Commercial with an integrated data strategy that takes advantage of AI and machine learning opportunities. By attending this event, you will learn how to do efficient scenario prediction to achieve the right risk-benefit balance in your portfolio, and how in the long run, you can adapt to the new normal with resilient portfolio performance informed by sound-decision making.


Key Topics

  • Roche discuss the impact of the crisis and how to refocus their PPM strategy
  • LEO Pharma discuss the intedependency between portfolio leadership and management for effective decision-making
  • Ipsen explore project management maturity and performance
  • Bayer reflect on the importance of strategi management and modelling in times of heightened uncertainty
  • Previous Attendees Include

    • Abbott Products Operations Ag
    • Abdi Ibrahim Ilac San. Ve. Tic. A.S.
    • Alkermes Pharma Ireland Limited
    • Almirall Hermal GmbH
    • Astra Zeneca
    • Baxalta
    • Baxter Global Marketing
    • Bayer Pharma AG
    • Biotest AG
    • Boehringer Ingelheim
    • Captario
    • Catenion
    • Cylad Consulting
    • Daiichi-Sankyo Development Ltd.
    • Evaluate
    • F.Hoffman-La Roche AG
    • Fresenius Kabi Deutschland
    • GSK
    • HEXAL AG
    • Janssen Pharmaceutica
    • Janssen Research & Development
    • Jerusalem Pharmaceuticals Company
    • LFB Biotechnologies
    • Medac GmbH
    • Merck Group
    • Mundipharma Research
    • Norgine
    • Novartis
    • Pierre Fabre Pharmaceutical Health Care
    • RB
    • Teva Pharmaceuticals
    • Vifor Pharma


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.






    Practical Insights From

    Yariv Hefez
    Vice President Head Global Oncology & Immuno-Oncology Strategic Asset Management
    Merck

    Dr. Heike Gielen-Haertwig
    Head of Porfolio Managment Preclinical Research
    Bayer

    Simone Frandsen
    Director, R&D Portfolio and Strategy
    LEO Pharma

    Lesley-Ann Norcross
    Head R&D Strategy and Operations
    Janssen/Johnson&Johnson

    Martine Mazzetti
    Head of Project Leadership
    VectivBio

    Tom Halliwell
    Director, Global Program Leader(Oncology)
    Ipsen

    Antonio Chiumiento
    Head of Project & Pipeline Management Office
    Menarini Ricerche

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” -Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” -VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” -Project Manager R&D, Chiesi
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Yiota Andreou


    marcus evans (Europe) Ltd
    PO Box 24797
    Cyprus

    Telephone:
    +357 22 849 404
    Fax: +357 22 849 310
    Email: YiotaA@marcusevanscy.com